Trial intelligence / Profile preview

Topical tranexamic acid to reduce blood loss after direct anterior hip replacement

TCTR20200428006Phase 3Completed

Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in Neck Of Femur Fracture, sponsored by none. Started Nov 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Neck Of Femur Fracture

Beyond the preview

Go deeper on TCTR20200428006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200428006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call